{"component": "clause", "props": {"groups": [{"size": 2, "snippet_links": [{"key": "the-parties-acknowledge", "type": "clause", "offset": [4, 27]}, {"key": "agrees-to", "type": "clause", "offset": [111, 120]}, {"key": "use-commercially-reasonable-efforts", "type": "clause", "offset": [121, 156]}, {"key": "technological-improvements", "type": "clause", "offset": [203, 229]}, {"key": "golf-cart", "type": "definition", "offset": [282, 291]}, {"key": "cost-savings", "type": "definition", "offset": [361, 373]}, {"key": "of-both-parties", "type": "clause", "offset": [418, 433]}], "snippet": "6.1 The parties acknowledge that Daramic is a technology leader in the battery separator industry, and Daramic agrees to use commercially reasonable efforts to keep abreast of and promptly implement all technological improvements, enhancements and/or advances in the manufacture of Golf Cart Separators. The parties intend to [*****] in all benefits (including cost savings) achieved through the efforts of Daramic or of both parties.\n6.2 [*****]", "samples": [{"hash": "951YRzFFiHF", "uri": "/contracts/951YRzFFiHF#research-development", "label": "Golf Cart Separator Supply Contract (Polypore International, Inc.)", "score": 21.0, "published": true}, {"hash": "icXAkvVAUVM", "uri": "/contracts/icXAkvVAUVM#research-development", "label": "Golf Cart Separator Supply Contract (Exide Corp)", "score": 18.0, "published": true}], "hash": "66cd01de53a5e15b803d605460ddfa50", "id": 2}, {"size": 2, "snippet_links": [{"key": "the-company-shall", "type": "clause", "offset": [0, 17]}, {"key": "to-develop", "type": "definition", "offset": [84, 94]}, {"key": "the-patents", "type": "clause", "offset": [95, 106]}, {"key": "new-intellectual-property", "type": "definition", "offset": [118, 143]}, {"key": "from-the-company", "type": "clause", "offset": [158, 174]}, {"key": "budget-process", "type": "definition", "offset": [239, 253]}, {"key": "section-91", "type": "definition", "offset": [270, 281]}, {"key": "responsible-for", "type": "clause", "offset": [311, 326]}], "snippet": "The Company shall contract with GRDG Sciences, LLC for the needed research in order to develop the patents as well as new intellectual property. Compensation from the Company for this work, if any, shall come through the business plan and budget process as set forth in Section 9.1. GRDG Sciences, LLC shall be responsible for any needed subcontracting.", "samples": [{"hash": "q4MQp3wMly", "uri": "/contracts/q4MQp3wMly#research-development", "label": "Stockholders Agreement", "score": 35.4624682261, "published": true}, {"hash": "kq3AdM43XWc", "uri": "/contracts/kq3AdM43XWc#research-development", "label": "Stockholders' Agreement (Impact Biomedical Inc.)", "score": 34.7905544148, "published": true}], "hash": "09a89b26fec13241e67110814484bd42", "id": 4}, {"size": 1, "snippet_links": [{"key": "the-parties-acknowledge", "type": "clause", "offset": [4, 27]}, {"key": "agrees-to", "type": "clause", "offset": [111, 120]}, {"key": "use-commercially-reasonable-efforts", "type": "clause", "offset": [121, 156]}, {"key": "technological-improvements", "type": "clause", "offset": [203, 229]}, {"key": "golf-cart", "type": "definition", "offset": [282, 291]}, {"key": "cost-savings", "type": "definition", "offset": [361, 373]}, {"key": "of-both-parties", "type": "clause", "offset": [418, 433]}, {"key": "if-during-the-term", "type": "clause", "offset": [448, 466]}, {"key": "a-third-party", "type": "clause", "offset": [564, 577]}, {"key": "subject-to-agreements", "type": "clause", "offset": [647, 668]}, {"key": "the-sale", "type": "clause", "offset": [700, 708]}, {"key": "disclosure-of", "type": "clause", "offset": [717, 730]}, {"key": "purchase-rights", "type": "definition", "offset": [778, 793]}, {"key": "period-of", "type": "definition", "offset": [800, 809]}, {"key": "availability-to-use", "type": "clause", "offset": [867, 886]}, {"key": "commercial-applications", "type": "clause", "offset": [914, 937]}, {"key": "exclusive-period", "type": "definition", "offset": [958, 974]}, {"key": "qualification-period", "type": "clause", "offset": [1005, 1025]}, {"key": "commencing-on", "type": "clause", "offset": [1058, 1071]}, {"key": "receipt-of", "type": "clause", "offset": [1072, 1082]}, {"key": "significant-interest", "type": "definition", "offset": [1195, 1215]}, {"key": "lack-of-response", "type": "clause", "offset": [1293, 1309]}, {"key": "lack-of-interest", "type": "clause", "offset": [1389, 1405]}], "snippet": "6.1 The parties acknowledge that Daramic is a technology leader in the battery separator industry, and Daramic agrees to use commercially reasonable efforts to keep abreast of and promptly implement all technological improvements, enhancements and/or advances in the manufacture of Golf Cart Separators. The parties intend to [*****] in all benefits (including cost savings) achieved through the efforts of Daramic or of both parties.\n6.2 When and if during the Term, Daramic, through its sole efforts and without agreements of confidentiality or exclusivity with a third party, develops a new Golf Cart Separator and if such new Separator is not subject to agreements with a third party restricting the sale, use or disclosure of such new Separator, Exide shall have exclusive purchase rights for a period of six (6) months after sample qualification and commercial availability to use such Separator material in commercial applications. Said six (6) month exclusive period shall commence after an Exide qualification period of not more than six (6) months commencing on receipt of the first Daramic sample material. If within the six (6) month qualification period, Exide determines it has no significant interest in said sample, Exide shall waive any exclusivity of the sampled material. A lack of response by the end of the six (6) month period shall in and of itself indicate Exide\u2019s lack of interest and shall waive any rights.", "samples": [{"hash": "fVyqdsldgmy", "uri": "/contracts/fVyqdsldgmy#research-development", "label": "Golf Cart Separator Supply Contract (Polypore International, Inc.)", "score": 21.0, "published": true}], "hash": "423e242029382fe5ae7b47695f3764d2", "id": 7}, {"size": 1, "snippet_links": [{"key": "responsible-for", "type": "clause", "offset": [18, 33]}, {"key": "the-research", "type": "clause", "offset": [34, 46]}, {"key": "development-and-marketing", "type": "clause", "offset": [48, 73]}, {"key": "licensed-products", "type": "clause", "offset": [81, 98]}, {"key": "by-the-parties", "type": "clause", "offset": [124, 138]}, {"key": "further-developments", "type": "clause", "offset": [152, 172]}, {"key": "development-efforts", "type": "clause", "offset": [208, 227]}, {"key": "commercially-reasonable", "type": "clause", "offset": [231, 254]}, {"key": "in-consideration-for", "type": "clause", "offset": [282, 302]}, {"key": "provide-the", "type": "clause", "offset": [319, 330]}, {"key": "development-support", "type": "clause", "offset": [343, 362]}], "snippet": "GATC shall (i) be responsible for the research, development and marketing of the Licensed Products; (ii) as mutually agreed by the Parties, pay IMS for further developments that is required to support GATC\u2019s development efforts at commercially reasonable and most favor able rates; in consideration for which IMS shall provide the agreed upon development support.", "samples": [{"hash": "9Sgg6zHH74V", "uri": "/contracts/9Sgg6zHH74V#research-development", "label": "License Agreement (Gatc Health Corp)", "score": 33.7392197125, "published": true}], "hash": "ca98322b7be8f04e50babf19e47404fa", "id": 10}, {"size": 1, "snippet_links": [{"key": "joint-research", "type": "definition", "offset": [36, 50]}], "snippet": "1.4.1 ICMAP and the RCP may conduct joint research and for this purpose ICMAP\u2019s students may be utilized as a resource;", "samples": [{"hash": "4yc41u0sNzh", "uri": "/contracts/4yc41u0sNzh#research-development", "label": "Memorandum of Understanding (Mou)", "score": 19.5484892171, "published": true}], "hash": "7f769cb1201a8784ad26f71f396eddfc", "id": 5}, {"size": 1, "snippet_links": [{"key": "the-parties-shall", "type": "clause", "offset": [0, 17]}, {"key": "in-good-faith", "type": "definition", "offset": [42, 55]}, {"key": "development-of", "type": "clause", "offset": [56, 70]}, {"key": "in-connection-with", "type": "clause", "offset": [103, 121]}, {"key": "phase-1", "type": "clause", "offset": [127, 134]}, {"key": "the-foregoing", "type": "definition", "offset": [190, 203]}, {"key": "seller-shall", "type": "clause", "offset": [216, 228]}], "snippet": "The Parties shall collaborate and discuss in good faith development of new and derivative technologies in connection with this Phase 1-3 Agreement (e.g. for [***], etc.). In connection with the foregoing commitment, Seller shall[***].", "samples": [{"hash": "46uJFwqhd0D", "uri": "/contracts/46uJFwqhd0D#research-development", "label": "Production Pricing Agreement (Solarcity Corp)", "score": 27.1622176591, "published": true}], "hash": "7cbb4017b4ac0fc1e076d003ac3fcd76", "id": 6}, {"size": 1, "snippet_links": [{"key": "terms-of-this-agreement", "type": "clause", "offset": [15, 38]}, {"key": "exclusive-control", "type": "clause", "offset": [69, 86]}, {"key": "relating-to", "type": "definition", "offset": [104, 115]}, {"key": "development-of", "type": "clause", "offset": [133, 147]}, {"key": "third-parties", "type": "clause", "offset": [230, 243]}, {"key": "sole-discretion", "type": "clause", "offset": [273, 288]}], "snippet": "Subject to the terms of this Agreement, Acceleron will have sole and exclusive control over all matters relating to the research and development of Collaboration Molecules and Products, itself or through one or more Affiliates or Third Parties selected by Acceleron in its sole discretion.", "samples": [{"hash": "e6V0gj2ji10", "uri": "/contracts/e6V0gj2ji10#research-development", "label": "Collaboration and License Agreement (Fulcrum Therapeutics, Inc.)", "score": 31.173853525, "published": true}], "hash": "5ab9a8b367f22d1277a37458ace457d7", "id": 9}, {"size": 3, "snippet_links": [{"key": "in-association-with", "type": "definition", "offset": [50, 69]}, {"key": "license-to", "type": "clause", "offset": [126, 136]}, {"key": "patent-rights", "type": "definition", "offset": [141, 154]}, {"key": "for-non", "type": "clause", "offset": [155, 162]}, {"key": "rd-activities", "type": "definition", "offset": [170, 184]}], "snippet": "NHC grants back to ANR, and the Inventors whether in association with ANR, UW-Madison, or elsewhere, a perpetual royalty-free license to the Patent Rights for non-profit R&D activities so long as such non-profit R&D activities do not compete with NHC's business.", "samples": [{"hash": "k5N6ynX8FYq", "uri": "/contracts/k5N6ynX8FYq#research-development", "label": "Patent Sub License", "score": 26.9154513407, "published": true}, {"hash": "iAXGrRBBCPE", "uri": "/contracts/iAXGrRBBCPE#research-development", "label": "Patent Sub License (Helius Medical Technologies, Inc.)", "score": 25.5311430527, "published": true}, {"hash": "73VVt2ce1N8", "uri": "/contracts/73VVt2ce1N8#research-development", "label": "Patent Sub License (Helius Medical Technologies, Inc.)", "score": 25.5311430527, "published": true}], "hash": "8b734a40e629f5e1b19072a2f2422b16", "id": 1}, {"size": 1, "snippet_links": [{"key": "the-competitive", "type": "clause", "offset": [0, 15]}, {"key": "business-environment", "type": "clause", "offset": [32, 52]}, {"key": "development-of-products", "type": "clause", "offset": [89, 112]}, {"key": "services-for", "type": "clause", "offset": [128, 140]}, {"key": "research-and-development", "type": "definition", "offset": [159, 183]}, {"key": "technological-advancements", "type": "clause", "offset": [267, 293]}, {"key": "products-and-services", "type": "definition", "offset": [303, 324]}, {"key": "product-life-cycle", "type": "definition", "offset": [343, 361]}, {"key": "new-designs", "type": "clause", "offset": [447, 458]}, {"key": "number-of", "type": "clause", "offset": [512, 521]}, {"key": "sponsored-research", "type": "definition", "offset": [583, 601]}, {"key": "cost-effective", "type": "clause", "offset": [694, 708]}, {"key": "intellectual-property-rights", "type": "definition", "offset": [831, 859]}, {"key": "new-knowledge", "type": "definition", "offset": [884, 897]}, {"key": "in-the-process", "type": "definition", "offset": [926, 940]}, {"key": "the-national", "type": "clause", "offset": [949, 961]}, {"key": "development-corporation", "type": "clause", "offset": [971, 994]}, {"key": "engaged-in", "type": "definition", "offset": [1023, 1033]}, {"key": "commercial-use", "type": "definition", "offset": [1243, 1257]}, {"key": "the-world", "type": "definition", "offset": [1313, 1322]}, {"key": "other-important", "type": "definition", "offset": [1414, 1429]}, {"key": "relate-to", "type": "definition", "offset": [1445, 1454]}, {"key": "development-projects", "type": "definition", "offset": [1468, 1488]}, {"key": "user-involvement", "type": "clause", "offset": [1520, 1536]}, {"key": "developed-product", "type": "definition", "offset": [1574, 1591]}, {"key": "prototype-development", "type": "clause", "offset": [1771, 1792]}], "snippet": "The competitive and challenging business environment demands continuous up-gradation and development of products, processes and services for sustained growth. Research and Development (R&D) contribute substantially towards achieving these goals. In the face of rapid technological advancements, various products and services have a very short product life cycle. R&D, in this respect, helps phase out products (& services) through introduction of new designs and technologies and improvement in quality. While a number of CPSEs have in-house R&D facilities, the others have gone for sponsored research through collaboration with Universities and reputed R&D institutions. Sponsored research is cost effective proposition for CPSEs which cannot afford to incur expenditure on in-house research. There is also a greater awareness of Intellectual Property Rights (IPR) and \u2018patenting\u2019of new knowledge gained and discoveries made in the process of R&D. The National Research Development Corporation (NRDC), a CPSE, is actively engaged in promoting, developing and commercializing technologies, knowhow, patent and processes generated through national R&D institutions, thus helping individual enterprises and institutions acquire IPR/ Patents for commercial use. Technological collaboration with leading companies of the world has been another approach adopted by CPSEs for upgrading their technological know-how. The other important aspects of R&D relate to execution of development projects which among others involve end user involvement in commercialization of indigenously developed product / technology, suitable empowerment / incentivisation / funding specially for capital intensive R&D in infrastructure like power sector, strengthening R&D infrastructure including prototype development, engaging experts at considerations other than price in knowledge/ competency gap areas etc.", "samples": [{"hash": "bEFymMcb1vt", "uri": "/contracts/bEFymMcb1vt#research-development", "label": "Mou", "score": 18.6132785763, "published": true}], "hash": "64be8dd5c9cdf8382014a6457ef1ff27", "id": 8}, {"size": 2, "snippet_links": [{"key": "continue-to-provide", "type": "clause", "offset": [18, 37]}, {"key": "testing-services", "type": "definition", "offset": [60, 76]}, {"key": "testing-laboratories", "type": "definition", "offset": [124, 144]}, {"key": "mutually-agreed", "type": "clause", "offset": [229, 244]}, {"key": "by-the-parties", "type": "clause", "offset": [250, 264]}, {"key": "provide-equipment", "type": "clause", "offset": [283, 300]}, {"key": "engineering-services", "type": "definition", "offset": [301, 321]}, {"key": "requested-by", "type": "definition", "offset": [414, 426]}, {"key": "payment-for", "type": "clause", "offset": [455, 466]}, {"key": "services-and", "type": "clause", "offset": [472, 484]}, {"key": "in-advance", "type": "clause", "offset": [528, 538]}, {"key": "the-parties-acknowledge", "type": "clause", "offset": [559, 582]}, {"key": "agrees-to", "type": "clause", "offset": [666, 675]}, {"key": "use-commercially-reasonable-efforts", "type": "clause", "offset": [676, 711]}, {"key": "technological-improvements", "type": "clause", "offset": [758, 784]}, {"key": "cost-savings", "type": "definition", "offset": [906, 918]}, {"key": "of-both-parties", "type": "clause", "offset": [963, 978]}], "snippet": "7.1 Daramic shall continue to provide separator and battery testing services to Exide such as are currently provided at its testing laboratories in Owensboro, Kentucky, and Hamburg, Germany, or at such other laboratory as may be mutually agreed upon by the parties.\n7.2 Daramic will provide equipment engineering services (enveloping and assembly equipment) and consultation to Exide's plants as may be reasonably requested by Exide. The exact nature and payment for such services and consultation shall be mutually agreed upon in advance by the parties.\n7.3 The parties acknowledge that Daramic is a technology leader in the battery separator industry, and Daramic agrees to use commercially reasonable efforts to keep abreast of and promptly implement all technological improvements, enhancements and/or advances in the manufacture of Separators. The parties intend to [*****] in all benefits (including cost savings) achieved through the efforts of Daramic or of both parties.\n7.4 [*****]", "samples": [{"hash": "lqfs2M4WXDQ", "uri": "/contracts/lqfs2M4WXDQ#research-development", "label": "Supply Agreement (Polypore International, Inc.)", "score": 21.0, "published": true}, {"hash": "6oOZtYwcnCP", "uri": "/contracts/6oOZtYwcnCP#research-development", "label": "Supply Agreement (Exide Corp)", "score": 18.0, "published": true}], "hash": "17f247deca5148aca1ab8a862e331341", "id": 3}], "next_curs": "Cl0SV2oVc35sYXdpbnNpZGVyY29udHJhY3RzcjkLEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2Ih1yZXNlYXJjaC1kZXZlbG9wbWVudCMwMDAwMDAwYQyiAQJlbhgAIAA=", "clause": {"title": "Research & Development", "size": 39, "parents": [["grant", "GRANT"], ["development-and-commercialization", "Development and Commercialization"], ["reserved", "Reserved"], ["question", "Question"], ["intellectual-property-rights", "Intellectual Property Rights"]], "children": [["", ""], ["first-sgen-antibody-target", "First SGEN Antibody Target"], ["research", "Research"], ["second-and-third-sgen-antibody-targets", "Second and Third SGEN Antibody Targets"], ["research-candidate-target-combinations", "Research Candidate Target Combinations"]], "id": "research-development", "related": [["job-development", "Job Development", "Job Development"], ["research-and-development", "Research and Development", "Research and Development"], ["joint-development", "Joint Development", "Joint Development"], ["staff-development", "Staff Development", "Staff Development"], ["project-development", "Project Development", "Project Development"]], "related_snippets": [], "updated": "2025-07-07T12:36:17+00:00"}, "json": true, "cursor": ""}}